Global Ponatinib Market Growth 2022-2028
- LP 4850257
- 72 Pages
- February 2022
- Pharmaceuticals
The United States Ponatinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ponatinib market, reaching US$ million by the year 2028. As for the Europe Ponatinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ponatinib players cover ARIAD Pharmaceuticals, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ponatinib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
45mg
15mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
CML
ALL
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
ARIAD Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ponatinib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ponatinib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ponatinib by Country/Region, 2017, 2022 & 2028
2.2 Ponatinib Segment by Type
2.2.1 45mg
2.2.2 15mg
2.3 Ponatinib Sales by Type
2.3.1 Global Ponatinib Sales Market Share by Type (2017-2022)
2.3.2 Global Ponatinib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ponatinib Sale Price by Type (2017-2022)
2.4 Ponatinib Segment by Application
2.4.1 CML
2.4.2 ALL
2.5 Ponatinib Sales by Application
2.5.1 Global Ponatinib Sale Market Share by Application (2017-2022)
2.5.2 Global Ponatinib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ponatinib Sale Price by Application (2017-2022)
3 Global Ponatinib by Company
3.1 Global Ponatinib Breakdown Data by Company
3.1.1 Global Ponatinib Annual Sales by Company (2020-2022)
3.1.2 Global Ponatinib Sales Market Share by Company (2020-2022)
3.2 Global Ponatinib Annual Revenue by Company (2020-2022)
3.2.1 Global Ponatinib Revenue by Company (2020-2022)
3.2.2 Global Ponatinib Revenue Market Share by Company (2020-2022)
3.3 Global Ponatinib Sale Price by Company
3.4 Key Manufacturers Ponatinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ponatinib Product Location Distribution
3.4.2 Players Ponatinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ponatinib by Geographic Region
4.1 World Historic Ponatinib Market Size by Geographic Region (2017-2022)
4.1.1 Global Ponatinib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ponatinib Annual Revenue by Geographic Region
4.2 World Historic Ponatinib Market Size by Country/Region (2017-2022)
4.2.1 Global Ponatinib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ponatinib Annual Revenue by Country/Region
4.3 Americas Ponatinib Sales Growth
4.4 APAC Ponatinib Sales Growth
4.5 Europe Ponatinib Sales Growth
4.6 Middle East & Africa Ponatinib Sales Growth
5 Americas
5.1 Americas Ponatinib Sales by Country
5.1.1 Americas Ponatinib Sales by Country (2017-2022)
5.1.2 Americas Ponatinib Revenue by Country (2017-2022)
5.2 Americas Ponatinib Sales by Type
5.3 Americas Ponatinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ponatinib Sales by Region
6.1.1 APAC Ponatinib Sales by Region (2017-2022)
6.1.2 APAC Ponatinib Revenue by Region (2017-2022)
6.2 APAC Ponatinib Sales by Type
6.3 APAC Ponatinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ponatinib by Country
7.1.1 Europe Ponatinib Sales by Country (2017-2022)
7.1.2 Europe Ponatinib Revenue by Country (2017-2022)
7.2 Europe Ponatinib Sales by Type
7.3 Europe Ponatinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ponatinib by Country
8.1.1 Middle East & Africa Ponatinib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ponatinib Revenue by Country (2017-2022)
8.2 Middle East & Africa Ponatinib Sales by Type
8.3 Middle East & Africa Ponatinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ponatinib
10.3 Manufacturing Process Analysis of Ponatinib
10.4 Industry Chain Structure of Ponatinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ponatinib Distributors
11.3 Ponatinib Customer
12 World Forecast Review for Ponatinib by Geographic Region
12.1 Global Ponatinib Market Size Forecast by Region
12.1.1 Global Ponatinib Forecast by Region (2023-2028)
12.1.2 Global Ponatinib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ponatinib Forecast by Type
12.7 Global Ponatinib Forecast by Application
13 Key Players Analysis
13.1 ARIAD Pharmaceuticals
13.1.1 ARIAD Pharmaceuticals Company Information
13.1.2 ARIAD Pharmaceuticals Ponatinib Product Offered
13.1.3 ARIAD Pharmaceuticals Ponatinib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ARIAD Pharmaceuticals Main Business Overview
13.1.5 ARIAD Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Ponatinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ponatinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 45mg
Table 4. Major Players of 15mg
Table 5. Global Ponatinib Sales by Type (2017-2022) & (K Units)
Table 6. Global Ponatinib Sales Market Share by Type (2017-2022)
Table 7. Global Ponatinib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Ponatinib Revenue Market Share by Type (2017-2022)
Table 9. Global Ponatinib Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Ponatinib Sales by Application (2017-2022) & (K Units)
Table 11. Global Ponatinib Sales Market Share by Application (2017-2022)
Table 12. Global Ponatinib Revenue by Application (2017-2022)
Table 13. Global Ponatinib Revenue Market Share by Application (2017-2022)
Table 14. Global Ponatinib Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Ponatinib Sales by Company (2020-2022) & (K Units)
Table 16. Global Ponatinib Sales Market Share by Company (2020-2022)
Table 17. Global Ponatinib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Ponatinib Revenue Market Share by Company (2020-2022)
Table 19. Global Ponatinib Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Ponatinib Producing Area Distribution and Sales Area
Table 21. Players Ponatinib Products Offered
Table 22. Ponatinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Ponatinib Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Ponatinib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Ponatinib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Ponatinib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Ponatinib Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Ponatinib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Ponatinib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Ponatinib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Ponatinib Sales by Country (2017-2022) & (K Units)
Table 34. Americas Ponatinib Sales Market Share by Country (2017-2022)
Table 35. Americas Ponatinib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Ponatinib Revenue Market Share by Country (2017-2022)
Table 37. Americas Ponatinib Sales by Type (2017-2022) & (K Units)
Table 38. Americas Ponatinib Sales Market Share by Type (2017-2022)
Table 39. Americas Ponatinib Sales by Application (2017-2022) & (K Units)
Table 40. Americas Ponatinib Sales Market Share by Application (2017-2022)
Table 41. APAC Ponatinib Sales by Region (2017-2022) & (K Units)
Table 42. APAC Ponatinib Sales Market Share by Region (2017-2022)
Table 43. APAC Ponatinib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Ponatinib Revenue Market Share by Region (2017-2022)
Table 45. APAC Ponatinib Sales by Type (2017-2022) & (K Units)
Table 46. APAC Ponatinib Sales Market Share by Type (2017-2022)
Table 47. APAC Ponatinib Sales by Application (2017-2022) & (K Units)
Table 48. APAC Ponatinib Sales Market Share by Application (2017-2022)
Table 49. Europe Ponatinib Sales by Country (2017-2022) & (K Units)
Table 50. Europe Ponatinib Sales Market Share by Country (2017-2022)
Table 51. Europe Ponatinib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Ponatinib Revenue Market Share by Country (2017-2022)
Table 53. Europe Ponatinib Sales by Type (2017-2022) & (K Units)
Table 54. Europe Ponatinib Sales Market Share by Type (2017-2022)
Table 55. Europe Ponatinib Sales by Application (2017-2022) & (K Units)
Table 56. Europe Ponatinib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Ponatinib Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Ponatinib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Ponatinib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Ponatinib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Ponatinib Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Ponatinib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Ponatinib Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Ponatinib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Ponatinib
Table 66. Key Market Challenges & Risks of Ponatinib
Table 67. Key Industry Trends of Ponatinib
Table 68. Ponatinib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Ponatinib Distributors List
Table 71. Ponatinib Customer List
Table 72. Global Ponatinib Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Ponatinib Sales Market Forecast by Region
Table 74. Global Ponatinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Ponatinib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Ponatinib Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Ponatinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Ponatinib Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Ponatinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Ponatinib Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Ponatinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Ponatinib Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Ponatinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Ponatinib Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Ponatinib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Ponatinib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Ponatinib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Ponatinib Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Ponatinib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Ponatinib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Ponatinib Revenue Market Share Forecast by Application (2023-2028)
Table 92. ARIAD Pharmaceuticals Basic Information, Ponatinib Manufacturing Base, Sales Area and Its Competitors
Table 93. ARIAD Pharmaceuticals Ponatinib Product Offered
Table 94. ARIAD Pharmaceuticals Ponatinib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. ARIAD Pharmaceuticals Main Business
Table 96. ARIAD Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Ponatinib
Figure 2. Ponatinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ponatinib Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ponatinib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ponatinib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 45mg
Figure 10. Product Picture of 15mg
Figure 11. Global Ponatinib Sales Market Share by Type in 2021
Figure 12. Global Ponatinib Revenue Market Share by Type (2017-2022)
Figure 13. Ponatinib Consumed in CML
Figure 14. Global Ponatinib Market: CML (2017-2022) & (K Units)
Figure 15. Ponatinib Consumed in ALL
Figure 16. Global Ponatinib Market: ALL (2017-2022) & (K Units)
Figure 17. Global Ponatinib Sales Market Share by Application (2017-2022)
Figure 18. Global Ponatinib Revenue Market Share by Application in 2021
Figure 19. Ponatinib Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Ponatinib Revenue Market Share by Company in 2021
Figure 21. Global Ponatinib Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Ponatinib Revenue Market Share by Geographic Region in 2021
Figure 23. Global Ponatinib Sales Market Share by Region (2017-2022)
Figure 24. Global Ponatinib Revenue Market Share by Country/Region in 2021
Figure 25. Americas Ponatinib Sales 2017-2022 (K Units)
Figure 26. Americas Ponatinib Revenue 2017-2022 ($ Millions)
Figure 27. APAC Ponatinib Sales 2017-2022 (K Units)
Figure 28. APAC Ponatinib Revenue 2017-2022 ($ Millions)
Figure 29. Europe Ponatinib Sales 2017-2022 (K Units)
Figure 30. Europe Ponatinib Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Ponatinib Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Ponatinib Revenue 2017-2022 ($ Millions)
Figure 33. Americas Ponatinib Sales Market Share by Country in 2021
Figure 34. Americas Ponatinib Revenue Market Share by Country in 2021
Figure 35. United States Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Ponatinib Sales Market Share by Region in 2021
Figure 40. APAC Ponatinib Revenue Market Share by Regions in 2021
Figure 41. China Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Ponatinib Sales Market Share by Country in 2021
Figure 48. Europe Ponatinib Revenue Market Share by Country in 2021
Figure 49. Germany Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Ponatinib Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Ponatinib Revenue Market Share by Country in 2021
Figure 56. Egypt Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Ponatinib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Ponatinib in 2021
Figure 62. Manufacturing Process Analysis of Ponatinib
Figure 63. Industry Chain Structure of Ponatinib
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
